This application is a 371 U.S. national phase of international application PCT/GB2002/005842, filed 20 Dec. 2002, which designated the U.S.; the entire content of which is incorporated herein by reference.
TECHNICAL FIELD
This invention pertains generally to the field of therapeutic agents, and more